Journal
CYTOTHERAPY
Volume 15, Issue 8, Pages 893-904Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.jcyt.2013.01.218
Keywords
bone marrow; cell therapy; hematopoietic stem cell; mesenchymal stromal cell
Categories
Funding
- Natural Science Foundation of Fujian Province [2010Y2006]
- National Natural Science Foundation of China [81272922]
Ask authors/readers for more resources
The prospective clinical use of multipotent mesenchymal stromal cells (MSCs) holds enormous promise for the treatment of a large number of degenerative and age-related diseases. In particular, autologous MSCs isolated from bone marrow (BM) are considered safe and have been extensively evaluated in clinical trials. Nevertheless, different efficacies have been reported, depending on the health status and age of the donor. In addition, the biological functions of BM-MSCs from patients with various diseases may be impaired. Furthermore, medical treatments such as long-term chemotherapy and immunomodulatory therapy may damage the BM microenvironment and affect the therapeutic potential of MSCs. Therefore, a number of practical problems must be addressed before autologous BM-MSCs can be widely applied with higher efficiency in patients. As such, this review focuses on various factors that directly influence the biological properties of BM-MSCs, and we discuss the possible mechanisms of these alterations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available